Literature DB >> 7531004

Anxiolytic effect of nitric oxide synthase inhibitors microinjected into the dorsal central grey.

F S Guimarães1, J C de Aguiar, E A Del Bel, G Ballejo.   

Abstract

Nitric oxide synthase (NOS) accounts for most of the NADPH-diaphorase neuronal activity in the brain. NADPH-diaphorase-positive neurones have been localized at the dorso-lateral part of the periaqueductal grey (PAG), a region related to anxiety. Microinjections of the NOS inhibitors L-NAME (10-200 nmol 0.5 microliter-1) and L-NOARG (10-100 nmol) at this site induced anxiolytic-like effects in the elevated plus maze. These effects, however, occurred only at a limited range of doses and the dose-effect curve had a bell shape, higher doses of both compounds tending to be anxiogenic. The anxiolytic effect of L-NAME was antagonized by a previous microinjection of L-arginine (50 nmol 0.5 microliter-1). These results suggest that NO may play a role in PAG neurotransmission involved in anxiety.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7531004     DOI: 10.1097/00001756-199410000-00022

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  20 in total

1.  Anxiolytic-like effects induced by nitric oxide synthase inhibitors microinjected into the medial amygdala of rats.

Authors:  Daniel Forestiero; Carlos Mora Manfrim; Francisco Silveira Guimarães; Rúbia Maria Weffort de Oliveira
Journal:  Psychopharmacology (Berl)       Date:  2005-12-15       Impact factor: 4.530

Review 2.  Role of nitric oxide on motor behavior.

Authors:  E A Del Bel; F S Guimarães; M Bermúdez-Echeverry; M Z Gomes; A Schiaveto-de-souza; F E Padovan-Neto; V Tumas; A P Barion-Cavalcanti; M Lazzarini; L P Nucci-da-Silva; D de Paula-Souza
Journal:  Cell Mol Neurobiol       Date:  2005-03       Impact factor: 5.046

3.  Combined treatment of ascorbic acid or alpha-tocopherol with dopamine receptor antagonist or nitric oxide synthase inhibitor potentiates cataleptic effect in mice.

Authors:  M Lazzarini; C Salum; E A Del Bel
Journal:  Psychopharmacology (Berl)       Date:  2005-10-15       Impact factor: 4.530

4.  An anxiolytic-like effect of hyperbaric oxygen in the mouse light/dark exploration test.

Authors:  Edina L Carlile; Donald Y Shirachi; Raymond M Quock
Journal:  Life Sci       Date:  2011-12-01       Impact factor: 5.037

5.  Antagonism of nitrous oxide-induced anxiolytic-like behavior in the mouse light/dark exploration procedure by pharmacologic disruption of endogenous nitric oxide function.

Authors:  Shuang Li; Yusuke Ohgami; Yang Dai; Raymond M Quock
Journal:  Psychopharmacology (Berl)       Date:  2003-02-13       Impact factor: 4.530

6.  Effects of nitric oxide synthase inhibition in the dorsolateral periaqueductal gray matter on ethanol withdrawal-induced anxiety-like behavior in rats.

Authors:  Vivian Taciany Bonassoli; Ewandro Braz Contardi; Humberto Milani; Rúbia Maria Weffort de Oliveira
Journal:  Psychopharmacology (Berl)       Date:  2013-03-15       Impact factor: 4.530

7.  Benzodiazepine receptor and serotonin 2A receptor modulate the aversive-like effects of nitric oxide in the dorsolateral periaqueductal gray of rats.

Authors:  Fabrício Araújo Moreira; Francisco Silveira Guimarães
Journal:  Psychopharmacology (Berl)       Date:  2004-07-22       Impact factor: 4.530

8.  Inhibition of neuronal nitric oxide reduces anxiety-like responses to pair housing.

Authors:  Joanna L Workman; Brian C Trainor; M Sima Finy; Randy J Nelson
Journal:  Behav Brain Res       Date:  2007-09-04       Impact factor: 3.332

9.  Anxiolytic effects induced by inhibition of the nitric oxide-cGMP pathway in the rat dorsal hippocampus.

Authors:  P C M Spolidório; M B Echeverry; M Iyomasa; F S Guimarães; E A Del Bel
Journal:  Psychopharmacology (Berl)       Date:  2007-07-28       Impact factor: 4.530

10.  Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects.

Authors:  Sâmia Regiane Lourenço Joca; Francisco Silveira Guimarães
Journal:  Psychopharmacology (Berl)       Date:  2006-03-01       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.